News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
141,880 Results
Type
Article (5471)
Company Profile (45)
Press Release (136357)
Section
Business (49586)
Career Advice (131)
Deals (8324)
Drug Delivery (9)
Drug Development (17774)
Employer Resources (20)
FDA (3064)
Job Trends (3629)
News (76676)
Policy (5663)
Tag
Academia (405)
Accelerated approval (4)
Adcomms (1)
Allergies (29)
Alliances (6078)
ALS (21)
Alzheimer's disease (442)
Antibody-drug conjugate (ADC) (70)
Approvals (3188)
Artificial intelligence (53)
Autoimmune disease (26)
Automation (5)
Bankruptcy (52)
Best Places to Work (3334)
BIOSECURE Act (1)
Biosimilars (36)
Biotechnology (35)
Bladder cancer (58)
Brain cancer (9)
Breast cancer (172)
Cancer (1082)
Cardiovascular disease (89)
Career advice (115)
CAR-T (36)
CDC (3)
Cell therapy (115)
Cervical cancer (9)
Clinical research (15691)
Collaboration (181)
Company closure (1)
Compensation (132)
Complete response letters (7)
COVID-19 (503)
CRISPR (8)
C-suite (68)
Cystic fibrosis (33)
Data (1564)
Depression (26)
Diabetes (107)
Diagnostics (1529)
Digital health (11)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (30)
Drug pricing (18)
Drug shortages (2)
Duchenne muscular dystrophy (64)
Earnings (38791)
Editorial (7)
Employer branding (6)
Employer resources (15)
Events (22560)
Executive appointments (69)
FDA (3866)
Fibrodysplasia Ossificans Progressiva (2)
Frontotemporal dementia (6)
Funding (183)
Gene editing (21)
Generative AI (4)
Gene therapy (76)
GLP-1 (232)
Government (789)
Grass and pollen (2)
Guidances (303)
Healthcare (4687)
HIV (19)
Huntington's disease (9)
IgA nephropathy (17)
Immunology and inflammation (48)
Immuno-oncology (9)
Indications (30)
Infectious disease (545)
Inflammatory bowel disease (41)
Inflation Reduction Act (3)
Influenza (25)
Intellectual property (37)
Interviews (12)
IPO (5424)
IRA (4)
Job creations (424)
Job search strategy (105)
JPM (39)
Kidney cancer (6)
Labor market (21)
Layoffs (121)
Leadership (4)
Legal (1056)
Liver cancer (19)
Longevity (1)
Lung cancer (163)
Lymphoma (113)
Machine learning (2)
Management (6)
Manufacturing (88)
MASH (53)
Medical device (3394)
Medtech (3406)
Mergers & acquisitions (3107)
Metabolic disorders (281)
Multiple sclerosis (45)
NASH (4)
Neurodegenerative disease (50)
Neuropsychiatric disorders (25)
Neuroscience (682)
Neurotech (1)
NextGen: Class of 2026 (1068)
Non-profit (832)
Now hiring (1)
Obesity (113)
Opinion (24)
Ovarian cancer (30)
Pain (27)
Pancreatic cancer (34)
Parkinson's disease (44)
Partnered (2)
Patents (74)
Patient recruitment (62)
Peanut (15)
People (6650)
Pharmaceutical (7)
Pharmacy benefit managers (3)
Phase 1 (4135)
Phase 2 (6645)
Phase 3 (6252)
Pipeline (2021)
Policy (16)
Postmarket research (558)
Preclinical (1437)
Press Release (12)
Prostate cancer (39)
Psychedelics (7)
Radiopharmaceuticals (52)
Rare diseases (159)
Real estate (645)
Recruiting (9)
Regulatory (4620)
Reports (16)
Research institute (396)
Resumes & cover letters (17)
Rett syndrome (7)
RNA editing (4)
RSV (12)
Schizophrenia (45)
Series A (16)
Series B (19)
Service/supplier (5)
Sickle cell disease (13)
Special edition (9)
Spinal muscular atrophy (38)
Sponsored (3)
Startups (386)
Stomach cancer (6)
Supply chain (13)
Tariffs (8)
The Weekly (3)
Vaccines (182)
Venture capital (18)
Weight loss (80)
Women's health (14)
Worklife (1)
Date
Today (20)
Last 7 days (126)
Last 30 days (461)
Last 365 days (7174)
2026 (584)
2025 (7040)
2024 (7852)
2023 (12425)
2022 (25888)
2021 (10841)
2020 (9929)
2019 (8582)
2018 (6335)
2017 (5599)
2016 (5006)
2015 (6444)
2014 (4391)
2013 (3098)
2012 (3475)
2011 (3626)
2010 (3374)
Location
Africa (97)
Alabama (15)
Arizona (34)
Arkansas (1)
Asia (8483)
Australia (1268)
California (2537)
Canada (776)
China (230)
Colorado (132)
Connecticut (96)
Delaware (120)
Europe (19788)
Florida (329)
Georgia (66)
Hawaii (1)
Idaho (9)
Illinois (140)
India (15)
Indiana (135)
Iowa (7)
Japan (109)
Kansas (22)
Kentucky (7)
Louisiana (10)
Maine (28)
Maryland (303)
Massachusetts (1528)
Michigan (59)
Minnesota (132)
Mississippi (1)
Missouri (21)
Montana (8)
Nebraska (5)
Nevada (26)
New Hampshire (12)
New Jersey (808)
New Mexico (2)
New York (714)
North Carolina (311)
North Dakota (1)
Northern California (1312)
Ohio (52)
Oklahoma (1)
Oregon (3)
Pennsylvania (618)
Rhode Island (2)
South America (194)
South Carolina (4)
Southern California (988)
Tennessee (26)
Texas (317)
United States (8713)
Utah (55)
Virginia (70)
Washington D.C. (6)
Washington State (198)
West Virginia (1)
Wisconsin (12)
141,880 Results for "26".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioCryst to Report Fourth Quarter 2025 Financial Results on February 26
February 5, 2026
·
1 min read
Press Releases
Immutep Quarterly Activities Report Q2 FY26
January 29, 2026
·
16 min read
Press Releases
Coloplast A/S - Interim Financial Report, Q1 2025/26
February 6, 2026
·
6 min read
Press Releases
Dentsply Sirona to Host Fourth Quarter and Full Year Conference Call on February 26
February 5, 2026
·
1 min read
Editorial
JPM26: Verizon Outage Unites Directionless Conference Goers
It doesn’t matter how many times you have traversed Union Square; no one knows which way is north, or where The Westin is in relation to the Ritz Carlton. A Verizon outage brought that into focus on Wednesday of JPM week.
January 15, 2026
·
1 min read
·
Annalee Armstrong
Business
JPM26: KalVista’s HAE Win Is a ‘Tale of Two Markets’
After winning a surprise approval for its hereditary angioedema drug Ekterly, KalVista is confident the oral offering will capture the lion’s share of the market for on-demand use.
January 21, 2026
·
3 min read
·
Dan Samorodnitsky
Press Releases
Arcus Biosciences Announces New Employment Inducement Grants - January 26, 2026
January 27, 2026
·
1 min read
Inflammatory bowel disease
Boehringer Commits up to $1.26B in IBD Pact With China’s Simcere
The cornerstone of the deal is SIM0709, which Simcere designed to target both TL1A and IL-23, crucial players in facilitating inflammation. Boehringer Ingelheim will advance the asset for inflammatory bowel diseases.
January 27, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Seer to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
February 6, 2026
·
1 min read
Press Releases
Teknova to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
February 6, 2026
·
1 min read
1 of 14,188
Next
